D. Schwartz, Editorial: Imaging and the Treatment of Crohn's Perianal Fistulas: To See Is to Believe, The American Journal of Gastroenterology, vol.125, issue.12, pp.2987-2996, 2009.
DOI : 10.1053/j.gastro.2007.05.051

S. Ingle, E. Loftus, and J. , The natural history of perianal Crohn's disease, Digestive and Liver Disease, vol.39, issue.10, pp.963-972, 2007.
DOI : 10.1016/j.dld.2007.07.154

D. Schwartz, E. Loftus, J. Tremaine, and W. , The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota, Gastroenterology, vol.122, issue.4, pp.875-80, 2002.
DOI : 10.1053/gast.2002.32362

S. Mahadev, J. Young, and W. Selby, Quality of Life in Perianal Crohn??s Disease: What Do Patients Consider Important?, Diseases of the Colon & Rectum, vol.54, issue.5, pp.579-85, 2011.
DOI : 10.1007/DCR.0b013e3182099d9e

A. Lapidus, Crohn???s disease in Stockholm County during 1990-2001: An epidemiological update, World Journal of Gastroenterology, vol.12, issue.1, pp.75-81, 2006.
DOI : 10.3748/wjg.v12.i1.75

A. Lapidus, O. Bernell, and G. Hellers, Clinical course of colorectal Crohn's disease: A 35-year follow-up study of 507 patients, Gastroenterology, vol.114, issue.6, pp.1151-60, 1998.
DOI : 10.1016/S0016-5085(98)70420-2

L. Peyrin-biroulet, E. Loftus, J. Colombel, and J. , The Natural History of Adult Crohn's Disease in Population-Based Cohorts, The American Journal of Gastroenterology, vol.132, issue.2, pp.289-97, 2010.
DOI : 10.1053/j.gastro.2008.09.053

L. Tang, P. Rawsthorne, and C. Bernstein, Are Perineal and Luminal Fistulas Associated in Crohn???s Disease? A Population-Based Study, Clinical Gastroenterology and Hepatology, vol.4, issue.9, pp.1130-1134, 2006.
DOI : 10.1016/j.cgh.2006.06.021

G. Hellers, O. Bergstrand, and S. Ewerth, Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease., Gut, vol.21, issue.6, pp.525-532, 1980.
DOI : 10.1136/gut.21.6.525

L. Peyrin-biroulet, P. Deltenre, and N. De-suray, Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials, Clinical Gastroenterology and Hepatology, vol.6, issue.6, pp.644-53, 2008.
DOI : 10.1016/j.cgh.2008.03.014

D. Present, P. Rutgeerts, and S. Targan, Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease, New England Journal of Medicine, vol.340, issue.18, pp.1398-405, 1999.
DOI : 10.1056/NEJM199905063401804

B. Sands, F. Anderson, and C. Bernstein, Infliximab Maintenance Therapy for Fistulizing Crohn's Disease, New England Journal of Medicine, vol.350, issue.9, pp.876-85, 2004.
DOI : 10.1056/NEJMoa030815

J. Colombel, D. Schwartz, and W. Sandborn, Adalimumab for the treatment of fistulas in patients with Crohn's disease, Gut, vol.58, issue.7, pp.940-948, 2009.
DOI : 10.1136/gut.2008.159251

G. Lichtenstein, S. Hanauer, and W. Sandborn, Management of Crohn's Disease in Adults, The American Journal of Gastroenterology, vol.7, issue.2, pp.465-83, 2009.
DOI : 10.1002/ibd.20014

G. Van-assche, A. Dignass, and W. Reinisch, The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations, Journal of Crohn's and Colitis, vol.4, issue.1, pp.63-101, 2010.
DOI : 10.1016/j.crohns.2009.09.009

R. Antakia, A. Shorthouse, and K. Robinson, Combined modality treatment for complex fistulating perianal Crohn???s disease, Colorectal Disease, vol.98, issue.suppl., 2012.
DOI : 10.1111/j.1463-1318.2012.03124.x

W. Gaertner, A. Decanini, and A. Mellgren, Does Infliximab Infusion Impact Results of Operative Treatment for Crohn??s Perianal Fistulas?, Diseases of the Colon & Rectum, vol.50, issue.11, pp.1754-60, 2007.
DOI : 10.1007/s10350-007-9077-3

M. Hotokezaka, T. Ikeda, and S. Uchiyama, Results of Seton Drainage and Infliximab Infusion for Complex Anal Crohn's Disease, Hepatogastroenterology, vol.58, issue.109, pp.1189-92, 2011.
DOI : 10.5754/hge09586

S. Hyder, S. Travis, and D. Jewell, Fistulating Anal Crohn??s Disease: Results of Combined Surgical and Infliximab Treatment, Diseases of the Colon & Rectum, vol.49, issue.12, pp.1837-1878, 2006.
DOI : 10.1007/s10350-006-0656-5

K. Karmiris, D. Bielen, and D. Vanbeckevoort, Long-Term Monitoring of Infliximab Therapy for Perianal Fistulizing Crohn's Disease by Using Magnetic Resonance Imaging, Clinical Gastroenterology and Hepatology, vol.9, issue.2, pp.130-136, 2011.
DOI : 10.1016/j.cgh.2010.10.022

P. Roumeguere, D. Bouchard, and F. Pigot, Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn??s disease: Results from a prospective study, Inflammatory Bowel Diseases, vol.17, issue.1, pp.69-76, 2011.
DOI : 10.1002/ibd.21405

D. Tougeron, G. Savoye, and C. Savoye-collet, Predicting Factors of Fistula Healing and Clinical Remission After Infliximab-Based Combined Therapy for Perianal Fistulizing Crohn???s Disease, Digestive Diseases and Sciences, vol.56, issue.8, pp.1746-52, 2009.
DOI : 10.1007/s10620-008-0545-y

M. Uchino, H. Ikeuchi, and T. Bando, Long-term efficacy of infliximab maintenance therapy for perianal Crohn???s disease, World Journal of Gastroenterology, vol.17, issue.9, pp.1174-1183, 2011.
DOI : 10.3748/wjg.v17.i9.1174

J. Satsangi, M. Silverberg, and S. Vermeire, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, vol.55, issue.6, pp.749-53, 2006.
DOI : 10.1136/gut.2005.082909

F. Schnitzler, H. Fidder, and M. Ferrante, Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort, Gut, vol.58, issue.4, pp.492-500, 2009.
DOI : 10.1136/gut.2008.155812

W. Sandborn, V. Fazio, and B. Feagan, AGA technical review on perianal Crohn???s disease, Gastroenterology, vol.125, issue.5, pp.1508-1538, 2003.
DOI : 10.1016/j.gastro.2003.08.025

G. Lichtenstein, R. Diamond, and C. Wagner, Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials, Alimentary Pharmacology & Therapeutics, vol.22, issue.Suppl 3, pp.210-236, 2009.
DOI : 10.1111/j.1365-2036.2009.04027.x

J. Colombel, W. Sandborn, and W. Reinisch, Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease, New England Journal of Medicine, vol.362, issue.15, pp.1383-95, 2010.
DOI : 10.1056/NEJMoa0904492

S. Ng, S. Plamondon, and A. Gupta, Prospective Evaluation of Anti-Tumor Necrosis Factor Therapy Guided by Magnetic Resonance Imaging for Crohn's Perineal Fistulas, The American Journal of Gastroenterology, vol.2, issue.12, pp.2973-86, 2009.
DOI : 10.1111/j.1572-0241.2008.02063.x

P. Tozer, S. Ng, and M. Siddiqui, Long-term MRI-guided combined anti-TNF-alpha and thiopurine therapy for crohn's perianal fistulas, Inflamm Bowel Dis, 2012.

D. Topstad, R. Panaccione, and J. Heine, Combined Seton Placement, Infliximab Infusion, and Maintenance Immunosuppressives Improve Healing Rate in Fistulizing Anorectal Crohn??s Disease, Diseases of the Colon & Rectum, vol.46, issue.5, pp.577-83, 2003.
DOI : 10.1007/s10350-004-6611-4

S. Van-der-hagen, C. Baeten, and P. Soeters, Anti-TNF-?? (Infliximab) Used as Induction Treatment in Case of Active Proctitis in a Multistep Strategy Followed by Definitive Surgery of Complex Anal Fistulas in Crohn's Disease: A Preliminary Report, Diseases of the Colon & Rectum, vol.48, issue.4, pp.758-67, 2005.
DOI : 10.1007/s10350-004-0828-0

P. Rutgeerts, Review article: treatment of perianal fistulizing Crohn's disease, Aliment Pharmacol Ther, vol.208, issue.3, pp.106-116, 2004.

. Montreal, 95% CI) Disease location L1 ? ileal L2 ? colonic L3 ? ileo-colonic L4 ? upper digestive tract Disease behavior B1 ? non-penetrating non-stricturing B2 ? stricturing B3 ? penetrating 19 (12.2, pp.5-21